Front Street Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Front Street Capital Management's PFE Position: Q1 2024 in Review
Front Street Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 4,697 shares — an estimated $135K sold.
Front Street Capital Management first reported a position in PFE in Q2 2016 and held it in 23 quarters. The position peaked at $293K in Q4 2021. 2,883 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Front Street Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Front Street Capital Management sold 4,697 Pfizer shares in Q1 2024, an estimated $135K.
- Front Street Capital Management first reported a position in Pfizer in Q2 2016 and held it in 23 quarters.
- Front Street Capital Management's Pfizer position peaked at $293K in Q4 2021.
- 2,883 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Front Street Capital Management's 13F filing for Q1 2024, filed 14 May 2024.